Asia Executives To Watch: New FDA China Director Named Amid ICH Push
The US FDA has sent its country director from Peru to build a closer relationship with the China FDA, while the CFDA's own medical device center is also going through a series of leadership changes.
You may also be interested in...
FDA has named a new head for India while Roche has appointed a new VP for its anti-infectives and specialty care business unit in China. Personnel changes have also been effected at Bayer, Cook Medical, and the biopharma startup Kira Therapeutics.
US FDA warning letters to Chinese firms may be on the increase, but ties with the Chinese regulator appear to be growing. US FDA showcases how to get more done in fast-changing China via aligning with China FDA's aspiration for quality and international harmonization.
Facing the aftermath of coronavirus disruption and supply chain reorganization, executives of multinational drug firms in China say the government needs to do more to help address a flurry of issues laid bare by the public health crisis.